Clinical Trials Logo

Clinical Trial Summary

Non-ablative and ablative devices are the most commonly used minimally-invasive treatments for skin rejuvenation. Current devices on the market for rejuvenation include the lasers such as the Fraxel Restore, the Halo, the Helios III, the Pico, the ThermiVa and the DiVa which have all been shown to have efficacy for the rejuvenation of the face, décolletage, hands and vagina. In this study we propose to compare the efficacy and side effect profile of these devices for skin rejuvenation of various areas of the body including the face, décolletage, hands, trunk, upper and lower extremities, and vagina.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03767972
Study type Interventional
Source University of California, Irvine
Contact
Status Enrolling by invitation
Phase N/A
Start date February 1, 2018
Completion date December 2026

See also
  Status Clinical Trial Phase
Completed NCT02910492 - Study of a Novel Laser for Skin Rejuvenation N/A
Completed NCT04640207 - The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment N/A
Completed NCT05840445 - Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles Phase 4
Active, not recruiting NCT05694286 - A Prospective Evaluation of Infraorbital Filler Injection N/A
Completed NCT01403597 - Evaluation of Non-ablative and Fractional Combination Treatment for Improvement in Skin's Appearance N/A
Completed NCT03189082 - Microbotox for Lower Face Rejuvenation N/A